According to Wallstreetcn, the Nasdaq Biotechnology Index fell more than 2% at the U.S. market open, with Dyne down 23.66%, Beam down 13.05%, Sarepta Therapeutics down 12.00%, LENZ Therapeutics down 8.05%, and Amgen down 7.19%, while Arcutis rose 3.95%, Pyxis Oncology rose 5.40%, Pharvaris NV rose 14.82%, and Roivant Sciences rose 14.09%.
